157 related articles for article (PubMed ID: 24195302)
1. Biomarkers in canine inflammatory bowel disease diagnostics.
Wdowiak M; Rychlik A; Kołodziejska-Sawerska A
Pol J Vet Sci; 2013; 16(3):601-10. PubMed ID: 24195302
[TBL] [Abstract][Full Text] [Related]
2. Canine inflammatory bowel disease: current and prospective biomarkers for diagnosis and management.
Collins MT
Compend Contin Educ Vet; 2013 Mar; 35(3):E5. PubMed ID: 23532922
[TBL] [Abstract][Full Text] [Related]
3. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.
Konstantinidis AΟ; Pardali D; Adamama-Moraitou KK; Gazouli M; Dovas CI; Legaki E; Brellou GD; Savvas I; Jergens AE; Rallis TS; Allenspach K
BMC Vet Res; 2020 Feb; 16(1):69. PubMed ID: 32087719
[TBL] [Abstract][Full Text] [Related]
4. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
[TBL] [Abstract][Full Text] [Related]
5. Decreased immunoglobulin A concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease.
Maeda S; Ohno K; Uchida K; Nakashima K; Fukushima K; Tsukamoto A; Nakajima M; Fujino Y; Tsujimoto H
J Vet Intern Med; 2013; 27(1):47-55. PubMed ID: 23216572
[TBL] [Abstract][Full Text] [Related]
6. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
[TBL] [Abstract][Full Text] [Related]
7. Cytokines in canine inflammatory bowel disease.
Kołodziejska-Sawerska A; Rychlik A; Depta A; Wdowiak M; Nowicki M; Kander M
Pol J Vet Sci; 2013; 16(1):165-71. PubMed ID: 23691593
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of disease activity for canine inflammatory bowel disease.
Jergens AE
J Am Anim Hosp Assoc; 2004; 40(6):437-45. PubMed ID: 15533963
[TBL] [Abstract][Full Text] [Related]
9. Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease.
Mancho C; Sainz A; García-Sancho M; Villaescusa A; Tesouro MA; Rodríguez-Franco F
J Vet Diagn Invest; 2010 Jul; 22(4):553-8. PubMed ID: 20622225
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of gastrointestinal macrophages/phagocytes in dogs with inflammatory bowel disease (IBD) and non-IBD dogs.
Wagner A; Junginger J; Lemensieck F; Hewicker-Trautwein M
Vet Immunol Immunopathol; 2018 Mar; 197():49-57. PubMed ID: 29475506
[TBL] [Abstract][Full Text] [Related]
11. Treatment of inflammatory bowel disease (IBD) in dogs and cats.
Malewska K; Rychlik A; Nieradka R; Kander M
Pol J Vet Sci; 2011; 14(1):165-71. PubMed ID: 21528730
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease.
Estruch JJ; Barken D; Bennett N; Krawiec DK; Ogilvie GK; Powers BE; Polansky BJ; Sueda MT
J Vet Intern Med; 2020 May; 34(3):1177-1186. PubMed ID: 32282988
[TBL] [Abstract][Full Text] [Related]
13. Urinary leukotriene E4 concentrations as a potential marker of inflammation in dogs with inflammatory bowel disease.
Im Hof M; Schnyder M; Hartnack S; Stanke-Labesque F; Luckschander N; Burgener IA
J Vet Intern Med; 2012; 26(2):269-74. PubMed ID: 22268894
[TBL] [Abstract][Full Text] [Related]
14. CD11c+ cells are significantly decreased in the duodenum, ileum and colon of dogs with inflammatory bowel disease.
Kathrani A; Schmitz S; Priestnall SL; Smith KC; Werling D; Garden OA; Allenspach K
J Comp Pathol; 2011 Nov; 145(4):359-66. PubMed ID: 21592490
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing Intestinal Lymphoma From Inflammatory Bowel Disease in Canine Duodenal Endoscopic Biopsy Samples.
Carrasco V; Rodríguez-Bertos A; Rodríguez-Franco F; Wise AG; Maes R; Mullaney T; Kiupel M
Vet Pathol; 2015 Jul; 52(4):668-75. PubMed ID: 25487412
[TBL] [Abstract][Full Text] [Related]
16. Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy.
Heilmann RM; Volkmann M; Otoni CC; Grützner N; Kohn B; Jergens AE; Steiner JM
Vet J; 2016 Sep; 215():96-100. PubMed ID: 27017054
[TBL] [Abstract][Full Text] [Related]
17. Does canine inflammatory bowel disease influence gut microbial profile and host metabolism?
Xu J; Verbrugghe A; Lourenço M; Janssens GP; Liu DJ; Van de Wiele T; Eeckhaut V; Van Immerseel F; Van de Maele I; Niu Y; Bosch G; Junius G; Wuyts B; Hesta M
BMC Vet Res; 2016 Jun; 12(1):114. PubMed ID: 27306031
[TBL] [Abstract][Full Text] [Related]
18. Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease.
Maeda S; Ohno K; Nakamura K; Uchida K; Nakashima K; Fukushima K; Tsukamoto A; Goto-Koshino Y; Fujino Y; Tsujimoto H
Vet J; 2012 Oct; 194(1):66-70. PubMed ID: 22483380
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease.
Simpson KW; Jergens AE
Vet Clin North Am Small Anim Pract; 2011 Mar; 41(2):381-98. PubMed ID: 21486642
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
